Quantinno Capital Management LP trimmed its holdings in shares of Centene Co. (NYSE:CNC – Free Report) by 67.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,604 shares of the company’s stock after selling 78,075 shares during the quarter. Quantinno Capital Management LP’s holdings in Centene were worth $2,278,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the stock. Capital Advisors Ltd. LLC boosted its position in Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after buying an additional 177 shares during the period. Hurley Capital LLC bought a new stake in shares of Centene during the fourth quarter valued at approximately $26,000. Rialto Wealth Management LLC purchased a new stake in shares of Centene in the fourth quarter valued at approximately $30,000. OFI Invest Asset Management bought a new position in shares of Centene during the 4th quarter worth $33,000. Finally, SRS Capital Advisors Inc. raised its holdings in shares of Centene by 73.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock valued at $38,000 after acquiring an additional 267 shares in the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.
Centene Trading Up 0.6%
NYSE CNC opened at $61.89 on Wednesday. Centene Co. has a 1 year low of $55.03 and a 1 year high of $80.59. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The company has a market capitalization of $30.80 billion, a PE ratio of 9.92, a P/E/G ratio of 0.80 and a beta of 0.48. The company has a fifty day moving average of $60.80 and a 200 day moving average of $60.44.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the stock. Jefferies Financial Group dropped their target price on shares of Centene from $64.00 to $61.00 and set a “hold” rating on the stock in a report on Tuesday, April 29th. StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Monday, April 28th. Robert W. Baird lowered their target price on Centene from $71.00 to $69.00 and set a “neutral” rating for the company in a report on Tuesday, April 15th. Argus downgraded Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Finally, Guggenheim restated a “neutral” rating on shares of Centene in a research note on Tuesday, April 29th. Seven analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat.com, Centene currently has an average rating of “Moderate Buy” and a consensus target price of $79.77.
Get Our Latest Report on Centene
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- Trading Halts Explained
- Top 5 Stocks Hedge Funds Are Buying Right Now
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- Compound Interest and Why It Matters When Investing
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.